Skip to content

The effect of Oliceridine Fumarate on postoperative analgesia and gastrointestinal function after laparoscopic radical gastric cancer surgery

The effect of Oliceridine Fumarate on postoperative analgesia and gastrointestinal function after laparoscopic radical gastric cancer surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095364
Enrollment
Unknown
Registered
2025-01-06
Start date
2024-11-25
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

control group:Postoperative self-controlled intravenous analgesia with sufentanil 1.5 µg/kg
Observation Group:Postoperative self-controlled intravenous analgesia with oxybutynin 0.35 mg/kg

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing elective laparoscopic gastric cancer surgery in our hospital from November 2024 to November 2025 were selected as clinical trial subjects; (2) 1 h <= expected duration of surgery <= 4 h; (3) no gender restriction; (4) age 18-65 years old; (5) 18 kg/m^2 <= body mass index (BMI) <= 29 kg/m^2; (6) ASA classification ?-?.

Exclusion criteria

Exclusion criteria: (1) the presence of pulmonary infection; (2) the presence of severe damage to target organs such as liver, kidney, heart, brain, etc.; (3) a history of difficult airway disease; (4) a known history of allergy to any component of the test drug or allergy to or contraindication to anaesthesia/analgesic medications used in the study; (5) the use of medications affecting the efficacy of postoperative analgesia, such as non-steroidal analgesic drugs, 1 day prior to randomisation.

Design outcomes

Primary

MeasureTime frame
Time of first postoperative defecation;

Secondary

MeasureTime frame
The pain (VAS) and sedation (RASS) scores of the patients immediately after awakening from surgery, at 2 hours, 6 hours, 12 hours, 24 hours, and 48 hours postoperatively.;Number of PCA single doses;Effective compression rate of intravenous self-controlled analgesic pumps in patients at 48 hours postoperatively (effective number of compressions/total number of compressions);Number of remedial analgesia;Number of remedial antiemetic sessions;Adverse reactions (dizziness, respiratory depression, nausea and vomiting, itching, urinary retention, etc.) within 48 hours after surgery;Postoperative gastrointestinal function I-FEED score (intake, nausea, vomiting and duration of symptoms);Time of first bowel movement;First time out of bed after surgery;Time of first postoperative meal;hospital fees;Length of hospitalization;

Countries

Chian

Contacts

Public ContactYaqin Huang

Hangzhou First People's Hospital

1021648643@qq.com+86 158 5824 3148

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026